Machine Learning – By Chemists, For Chemists
Discover the future of drug discovery with ANYO Labs' AI-driven methods. Developed by leading researchers from Gothenburg University, our cutting-edge technology has been proven to deliver results with astonishing speed and accuracy. By taking a chemistry-first approach when developing our machine learning models, we have set a new standard in de novo drug discovery. Don't settle for less when it comes to advancing your research. Experience the power of ANYO Labs' AI today and take your drug discovery research to the next level.
Screening of Libraries
Revolutionize your drug discovery processwith i-TripleD, the ultimate screening and scoring tool from ANYO Labs. Withi-TripleD, you can quickly and easily filter through vast libraries ofcompounds to identify potential drug candidates that align with your specifictargets. Experience the power of i-TripleD today.
ADMET and Synthesis
At ANYO Labs, we specialize in utilizing ADMET (Absorbtion, Distribution, Metabolism, Excretion, and Toxicity) criteria to rank and filter potential drug
candidates, ensuring that only the most promising compounds move forward in the development process. Additionally, our synthetic accessibility assessment further supports the identification of the most viable and cost-effective drug candidates. Contact us now to learn more about our services and pricing options.
de novo Drug Discovery
Unlock the full potential of your drug discovery research with our cutting-edge de novo generative modules. At ANYO Labs, we specialize in rapidly exploring completely new regions of druglike chemical space to identify new chemical entities and scaffolds, or generate and screen thousands of analogues per second. Using our intelligent scaffold optimizer, we can furthermore advance your Lead optimization by tailoring compounds with unprecedented binding affinities towards your target of interest.